Back to Search
Start Over
Supplementary Figure 3 from GSK1838705A inhibits the insulin-like growth factor-1 receptor and anaplastic lymphoma kinase and shows antitumor activity in experimental models of human cancers
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- Supplementary Figure 3. A. Time course of IGF-1R inhibition in vivo. B. Effect of GSK1838705A on IGF-1R signaling in vivo.
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....2da4c5bfbaad320a1cf0248ce348a22c
- Full Text :
- https://doi.org/10.1158/1535-7163.22485578